1. Optimization, and biological evaluation of 3-O-β-chacotriosyl betulinic acid amide derivatives as novel small-molecule Omicron.
- Author
-
Liu, Mingjian, Wang, Jinshen, Shi, Shanshan, Gao, Yongfeng, Zhang, Yixiao, Yuan, Ziying, Huang, Enlin, Li, Sumei, Liu, Shuwen, and Song, Gaopeng
- Subjects
- *
SARS-CoV-2 Omicron variant , *BETULINIC acid , *AMIDES , *SAPONINS , *AMIDE derivatives , *ACID derivatives , *SARS-CoV-2 - Abstract
SARS-CoV-2 Omicron viruses possess a high antigenic shift, and the approved anti-SARS-CoV-2 drugs are extremely limited, which makes the development of new antiviral drugs for the clinical treatment and prevention of SARS-CoV-2 outbreaks imperative. We have previously discovered a new series of markedly potent small-molecule inhibitors of SARS-CoV-2 virus entry, exampled by the hit compound 2. Here, we report a further study of bioisosteric replacement of the eater linker at the C-17 position of 2 with a variety of aromatic amine moieties, followed by a focused structure-activity relationship study, leading to the discovery of a series of novel 3- O - β -chacotriosyl BA amide derivatives as small-molecule Omicron fusion inhibitors with improved potency and selectivity index. Particularly, our medicinal chemistry efforts have resulted in a potent, and efficacious lead compound S-10 with appreciable pharmacokinetic properties, which exhibited broad-spectrum potency against Omicron and other variants with EC 50 values ranging from 0.82 to 5.45 μM. Mutagenesis studies confirmed that inhibition of Omicron viral entry was mediated by the direct interaction with S in the prefusion state. These results reveal that S-10 is suitable for further optimization as Omicron fusion inhibitors, with the potential to be developed as therapeutic agents for the treatment and control of SARS-CoV-2 ant its variants infections. [Display omitted] • A set of 3- O -β-chacotriosyl BA saponins were synthesized and characterized based on the bioisosterism and SBDD strategies. • These title saponins exhibited strong inhibition toward Omicron. • Intensive structure-activity relationships were conducted. • S-10 showed broad-spectrum anti-SARS-CoV-2 activities by blocking membrane fusion. • S-10 displayed promising pharmacokinetic properties in vitro. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF